(Q44092045)

29 November 2017

Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors (English)

1 reference

29 November 2017

5

Malte Kelm

1 reference

29 November 2017

Artur-Aron Weber

1

1 reference

29 November 2017

Dan Meila

2

1 reference

29 November 2017

Collin Jacobs

3

1 reference

29 November 2017

Stephanie Weber

4

1 reference

29 November 2017

Bodo E Strauer

6

1 reference

29 November 2017

Rainer B Zotz

7

1 reference

29 November 2017

Rüdiger E Scharf

8

1 reference

29 November 2017

Karsten Schrör

9

1 reference

29 November 2017

1 April 2002

1 reference

29 November 2017

1 reference

29 November 2017

106

1 reference

29 November 2017

25-29

1 reference

29 November 2017

1

1 reference

Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Reduced inhibition by abciximab in platelets with the PlA2 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Genotyping of human platelet antigen-1 by gene amplification and labelling in one system and automated fluorescence correlation spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900083-X

7 January 2021

10.1016/S0049-3848(02)00083-X

Identifiers

DOI

1 reference

29 November 2017

1 reference